Another evidence about the strong association between BTG2 expression and visceral metastatic disease in breast cancer patients (p < 0.001, 95% confidence interval 1.43–4.27) has been reported and it was independent of other clinico-pathologic features66. The gene discussed is BTG2; the disease is breast cancer.